|
1
|
Jansson M, von Heymann-Horan AB, Rasmussen
BK, Albieri V, Frederiksen K, Suppli N, Dalton SO, Johansen C and
Bidstrup PE: Risk for use of antidepressants, anxiolytics, and
hypnotics in partners of glioma patients-A nationwide study
covering 19 years of prescriptions. Psychooncology. 27:1930–1936.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Ostrom QT, Bauchet L, Davis FG, Deltour I,
Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh
KM, et al: The epidemiology of glioma in adults: A ‘state of the
science’ review. Neuro Oncol. 16:896–913. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Affronti ML, Jackman JG, McSherry F,
Herndon JE II, Massey EC Jr, Lipp E, Desjardins A, Friedman HS,
Vlahovic G and Peters KB: Phase II study to evaluate the efficacy
and safety of rilotumumab and bevacizumab in subjects with
recurrent malignant glioma. Oncologist. 23:889–e98. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ravn MB, Jakola AS, Reinertsen I, Sagberg
LM, Unsgard G and Solheim O: The diagnostic properties of
intraoperative ultrasound in glioma surgery and factors associated
with gross total tumor resection. World Neurosurg. 115:e129–e136.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Parente A, van Waarde A, Shoji A, de Paula
FD, Maas B, Zijlma R, Dierckx R, Langendijk JA, de Vries EFJ and
Doorduin J: PET imaging with S-[11 C]Methyl-L-cysteine
and L-[Methyl-11 C]Methionine in rat models of glioma,
glioma radiotherapy, and neuroinflammation. Mol Imaging Biol.
20:465–472. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fang Y, Jiang Y, Zou Y, Meng F, Zhang J,
Deng C, Sun H and Zhong Z: Targeted glioma chemotherapy by cyclic
RGD peptide-functionalized reversibly core-crosslinked
multifunctional poly(ethylene glycol)-b-poly(epsilon-caprolactone)
micelles. Acta Biomater. 50:396–406. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dai X, Ma C, Lan Q and Xu T: 3D bioprinted
glioma stem cells for brain tumor model and applications of drug
susceptibility. Biofabrication. 8(45005)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Griveau A, Seano G, Shelton SJ, Kupp R,
Jahangiri A, Obernier K, Krishnan S, Lindberg OR, Yuen TJ, et al: A
glial signature and Wnt7 signaling regulate glioma-vascular
interactions and tumor microenvironment. Cancer Cell.
33:874–889.e7. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ruan H, Chai Z, Shen Q, Chen X, Su B, Xie
C, Zhan C, Yao S, Wang H, Zhang M, et al: A novel peptide ligand
RAP12 of LRP1 for glioma targeted drug delivery. J Control Release.
279:306–315. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Khan MB, Schneider JR, Kwan K and Boockvar
JA: Epigentic regulators of glioma stem cells are potential
therapeutic targets. Neurosurgery. 82:E104–E105. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kim H, Yi SS, Lee HK, Heo TH, Park SK, Jun
HS, Song KD and Kim SJ: Antiproliferative effect of vine stem
extract from spatholobus suberectus Dunn on Rat C6 glioma cells
through regulation of ROS, mitochondrial depolarization, and P21
protein expression. Nutr Cancer. 70:605–619. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nan Y, Guo H, Guo LY, Wang L, Ren BC, Yu
K, Huang Q and Zhong Y: miRNA-451 inhibits glioma cell
proliferation and invasion through the mTOR/HIF-1alpha/VEGF
signaling pathway by targeting CAB39. Hum Gene Ther Clin Dev.
29:156–166. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lu F, Ye Y, Zhang H, He X, Sun X, Yao C,
Mao H, He X, Qian C, Wang B, et al: miR-497/Wnt3a/c-jun feedback
loop regulates growth and epithelial-to-mesenchymal transition
phenotype in glioma cells. Int J Biol Macromol. 120:985–991.
2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chai C, Song LJ, Han SY, Li XQ and Li M:
MicroRNA-21 promotes glioma cell proliferation and inhibits
senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT
signaling pathway. CNS Neurosci Ther. 24:369–380. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hui W, Yuntao L, Lun L, WenSheng L,
ChaoFeng L, HaiYong H and Yueyang B: MicroRNA-195 inhibits the
proliferation of human glioma cells by directly targeting cyclin D1
and cyclin E1. PLoS One. 8(e54932)2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yan D, Hao C, Xiao-Feng L, Yu-Chen L,
Yu-Bin F and Lei Z: Molecular mechanism of Notch signaling with
special emphasis on microRNAs: Implications for glioma. J Cell
Physiol. 234:158–170. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gu G, Wang L, Zhang J, Wang H, Tan T and
Zhang G: MicroRNA-384 inhibits proliferation migration and invasion
of glioma by targeting at CDC42. Onco Targets Ther. 11:4075–4085.
2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wu Q, Xu L, Wang C, Fan W, Yan H and Li Q:
MicroRNA-124-3p represses cell growth and cell motility by
targeting EphA2 in glioma. Biochem Biophys Res Commun.
503:2436–2442. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
von Ungern-Sternberg SNI, Zernecke A and
Seizer P: Extracellular matrix metalloproteinase inducer EMMPRIN
(CD147) in cardiovascular disease. Int J Mol Sci.
19(507)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Horikawa Y, Watanabe M, Sadahira T,
Ariyoshi Y, Kobayashi Y, Araki M, Wada K, Ochiai K, Li SA and Nasu
Y: Overexpression of REIC/Dkk-3 suppresses the expression of CD147
and inhibits the proliferation of human bladder cancer cells. Oncol
Lett. 14:3223–3228. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhou Y, Di Z, Li X, Shan Y, Li W, Zhang H
and Xiao Y: Chemical proteomics reveal CD147 as a functional target
of Pseudolaric acid B in human cancer cells. Chem Commun (Camb).
53:8671–8674. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jia L, Zhou H, Wang S, Cao J, Wei W and
Zhang J: Deglycosylation of CD147 down-regulates Matrix
Metalloproteinase-11 expression and the adhesive capability of
murine hepatocarcinoma cell HcaF in vitro. IUBMB Life. 58:209–216.
2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang Z, Zhao Y, Jiang L, Miao X, Zhou H
and Jia L: Glycomic alterations are associated with multidrug
resistance in human leukemia. Int J Biochem Cell Biol.
44:1244–1253. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Arora M and Mane DR: Immunohistochemical
expression of extracellular matrix metalloproteinase inducer
(EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral
squamous cell carcinoma. J Oral Maxillofac Pathol. 22:279–280.
2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zheng HC and Gong BC: CD147 expression was
positively linked to aggressiveness and worse prognosis of gastric
cancer: A meta and bioinformatics analysis. Oncotarget.
8:90358–90370. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Yin H, Shao Y and Chen X: The effects of
CD147 on the cell proliferation, apoptosis, invasion, and
angiogenesis in glioma. Neurol Sci. 38:129–136. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li H, Xi Z, Dai X, Wu W, Li Y, Liu Y and
Zhang H: CD147 and glioma: A meta-analysis. J Neurooncol.
134:145–156. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wijnenga M, French PJ, Dubbink HJ, Dinjens
W, Atmodimedjo PN, Kros JM, Fleischeuer R, Dirven C, Vincent A and
van den Bent MJ: Prognostic relevance of mutations and copy number
alterations assessed with targeted next generation sequencing in
IDH mutant grade II glioma. J Neurooncol. 139:349–357.
2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Andronesi OC, Arrillaga-Romany IC, Ly KI,
Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER,
Chi AS, et al: Pharmacodynamics of mutant-IDH1 inhibitors in glioma
patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.
Nat Commun. 9(1474)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Subburayan K, Thayyullathil F,
Pallichankandy S, Rahman A and Galadari S: Par-4-dependent p53
up-regulation plays a critical role in thymoquinone-induced
cellular senescence in human malignant glioma cells. Cancer Lett.
426:80–97. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu SJ, Yang TC, Yang ST, Chen YC and
Tseng YY: Biodegradable hybrid-structured nanofibrous membrane
supported chemoprotective gene therapy enhances chemotherapy
tolerance and efficacy in malignant glioma rats. Artif Cells
Nanomed Biotechnol. 46 (Suppl 2):S515–S526. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Chen X, Li D, Gao Y, Cao Y and Hao B:
Histone deacetylase SIRT6 inhibits glioma cell growth through
down-regulating NOTCH3 expression. Acta Biochim Biophys Sin
(Shanghai). 50:417–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cortez MA, Anfossi S, Ramapriyan R, Menon
H, Atalar SC, Aliru M, Welsh J and Calin GA: Role of miRNAs in
immune responses and immunotherapy in cancer. Genes Chromosomes
Cancer. 58:244–253. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Hu C, Dong X, Wu J, Xiao F, Shang J, Liu
L, Yang Y, Luo D, Li Q, Song Q, et al: CD147 overexpression may
serve as a promising diagnostic and prognostic marker for gastric
cancer: Evidence from original research and literature. Oncotarget.
8:30888–30899. 2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang X, Tian T, Zhang X, Liu C and Fang
X: Elevated CD147 expression is associated with shorter overall
survival in non-small cell lung cancer. Oncotarget. 8:37673–37680.
2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fei F, Li S, Fei Z and Chen Z: The roles
of CD147 in the progression of gliomas. Expert Rev Anticancer Ther.
15:1351–1359. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Sameshima T, Nabeshima K, Toole BP,
Yokogami K, Okada Y, Goya T, Koono M and Wakisaka S: Expression of
emmprin (CD147), a cell surface inducer of matrix
metalloproteinases, in normal human brain and gliomas. Int J
Cancer. 88:21–27. 2000.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hu Z, Cai M, Deng L, Zhu L, Gao J, Tan M,
Liu J and Lin B: The fucosylated CD147 enhances the autophagy in
epithelial ovarian cancer cells. Oncotarget. 7:82921–82932.
2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kendrick AA, Schafer J, Dzieciatkowska M,
Nemkov T, D'Alessandro A, Neelakantan D, Ford HL, Pearson CG,
Weekes CD, Hansen KC and Eisenmesser EZ: CD147: A small molecule
transporter ancillary protein at the crossroad of multiple
hallmarks of cancer and metabolic reprogramming. Oncotarget.
8:6742–6762. 2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Martins SF, Amorim R, Viana-Pereira M,
Pinheiro C, Costa RF, Silva P, Couto C, Alves S, Fernandes S,
Vilaca S, et al: Significance of glycolytic metabolism-related
protein expression in colorectal cancer, lymph node and hepatic
metastasis. BMC Cancer. 16(535)2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ju X, Liang S, Zhu J, Ke G, Wen H and Wu
X: Extracellular matrix metalloproteinase inducer
(CD147/BSG/EMMPRIN)-induced radioresistance in cervical cancer by
regulating the percentage of the cells in the G2/m phase of the
cell cycle and the repair of DNA double-strand breaks (DSBs). Am J
Transl Res. 8:2498–2511. 2016.PubMed/NCBI
|
